tki-resistant egfr-mutant nsclc
Published 9 years ago • 3K plays • Length 20:35Download video MP4
Download video MP3
Similar videos
-
21:09
mechanisms of resistance to egfr tki and new treatment strategies
-
13:26
debate: drug of choice for exon 19 del egfr mutant nsclc - any egfr tki
-
20:24
targeted treatment with egfr tkis: front line options
-
21:35
long term management of egfr-mutant nsclc -tsao
-
19:53
managing progression in egfr-mutant nsclc patients: potential impact of 2nd and 3rd generation tkis?
-
44:03
egfr: the challenge of primary and secondary resistance
-
13:06
managing t790-negative egfr-mutated nsclc
-
20:07
acquired egfr resistance: what are the current therapeutic strategies?
-
37:23
nsclc: integrating egfr-inhibiting therapies into clinical pathways for first-line treatment
-
8:00
egfr tki resistance: targeting met amplification
-
23:10
egfr mutation positive tumors: treatment strategies in front line and at relapse
-
14:30
adjuvant therapy for egfr mutant nsclc
-
20:18
understanding, preventing, and delaying egfr resistance in the era of osimertinib
-
10:39
egfr tki resistance: progress and challenges
-
16:22
debate: drug of choice for exon 19 del egfr mutant nsclc - afatinib
-
20:27
managing egfr-resistant disease: t790 and beyond
-
17:27
how, when, and where to utilize erlotinib, afatinib, and gefitinib in egfr positive nsclc
-
3:04
ivonescimab benefit for egfr mutant nsclc patients who failed tki therapy
-
45:43
egfr mutant lung cancer: 2013 update